JAMA ophthalmology۲۰۲۶کارآزمایی بالینی تصادفی۱ استنادنمایه شده در PubMed
John D Pitcher, Adrian Hock Chuan Koh, Colin S Tan, Priya Vakharia, Nicholas Dagincourt, Shriji Patel, Ming Yang, Philippe Margaron, Roberto Gallego-Pinazo
چکیده
In the TENAYA and LUCERNE randomized clinical trials (RCTs), approximately 80% of study participants with treatment-naive neovascular age-related macular degeneration (nAMD) achieved at least every-12-week faricimab dosing at week 112. Subsequent post hoc analyses showed more rapid drying with…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1001/jamaophthalmol.2025.6365